📄 Read our new white paper: ‘ The Case for Smarter GLP-1 Utilization: Cost, Coverage, and Clinical Outcomes '
Details

Media & press

The Problem with Ozempic

Dr. Karan Explores - Podcast
-
-
June 14, 2024
-
Dr. Karan Rajan
“Ozempic has changed the conversation around obesity. Unfortunately a lot of people are misusing the medication.” -Dr Andres Acosta
Highlights:

Dr Andres Acosta is an obesity expert at the Mayo Clinic, and regularly helps patients achieve double digit weight loss thanks to semaglutide, often branded as Ozempic or Wegovy. But as healthy people look to it for a quick fix, he raises a red flag about the drug.

← Media & Press